vs

Side-by-side financial comparison of HARROW, INC. (HROW) and National Bank Holdings Corp (NBHC). Click either name above to swap in a different company.

National Bank Holdings Corp is the larger business by last-quarter revenue ($126.8M vs $89.1M, roughly 1.4× HARROW, INC.). National Bank Holdings Corp runs the higher net margin — 16.4% vs 7.4%, a 9.0% gap on every dollar of revenue. Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 14.0%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Old National Bank is an American regional bank with nearly 200 retail branches operated by Old National Bancorp and based in Chicago and Evansville, Indiana. With assets at $48.5 billion and 250 banking centers, Old National Bancorp is the largest financial services bank holding company headquartered in Indiana and one of the top 30 banking companies in the U.S. Old National Bank has locations in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Tennessee, and Wisconsin.

HROW vs NBHC — Head-to-Head

Bigger by revenue
NBHC
NBHC
1.4× larger
NBHC
$126.8M
$89.1M
HROW
Higher net margin
NBHC
NBHC
9.0% more per $
NBHC
16.4%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
14.0%
NBHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
NBHC
NBHC
Revenue
$89.1M
$126.8M
Net Profit
$6.6M
$20.8M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
16.4%
Revenue YoY
33.3%
Net Profit YoY
-2.2%
-14.2%
EPS (diluted)
$0.20
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
NBHC
NBHC
Q1 26
$126.8M
Q4 25
$89.1M
$100.6M
Q3 25
$71.6M
$108.9M
Q2 25
$63.7M
$104.5M
Q1 25
$47.8M
$102.1M
Q4 24
$66.8M
$101.3M
Q3 24
$49.3M
$106.0M
Q2 24
$48.9M
$97.6M
Net Profit
HROW
HROW
NBHC
NBHC
Q1 26
$20.8M
Q4 25
$6.6M
$16.0M
Q3 25
$1.0M
$35.3M
Q2 25
$5.0M
$34.0M
Q1 25
$-17.8M
$24.2M
Q4 24
$6.8M
$28.2M
Q3 24
$-4.2M
$33.1M
Q2 24
$-6.5M
$26.1M
Gross Margin
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
17.5%
19.0%
Q3 25
20.6%
39.6%
Q2 25
17.9%
39.8%
Q1 25
-23.5%
29.2%
Q4 24
19.3%
34.3%
Q3 24
2.7%
37.6%
Q2 24
3.1%
32.5%
Net Margin
HROW
HROW
NBHC
NBHC
Q1 26
16.4%
Q4 25
7.4%
15.9%
Q3 25
1.4%
32.4%
Q2 25
7.8%
32.6%
Q1 25
-37.2%
23.7%
Q4 24
10.1%
27.8%
Q3 24
-8.6%
31.2%
Q2 24
-13.2%
26.8%
EPS (diluted)
HROW
HROW
NBHC
NBHC
Q1 26
$0.46
Q4 25
$0.20
$0.42
Q3 25
$0.03
$0.92
Q2 25
$0.13
$0.88
Q1 25
$-0.50
$0.63
Q4 24
$0.19
$0.72
Q3 24
$-0.12
$0.86
Q2 24
$-0.18
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
NBHC
NBHC
Cash + ST InvestmentsLiquidity on hand
$72.9M
$472.8M
Total DebtLower is stronger
$250.0M
$202.1M
Stockholders' EquityBook value
$52.4M
$1.7B
Total Assets
$399.5M
$12.6B
Debt / EquityLower = less leverage
4.77×
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
NBHC
NBHC
Q1 26
$472.8M
Q4 25
$72.9M
$417.1M
Q3 25
$74.3M
$555.6M
Q2 25
$53.0M
$296.5M
Q1 25
$66.7M
$246.3M
Q4 24
$47.2M
$127.8M
Q3 24
$72.6M
$180.8M
Q2 24
$71.0M
$145.0M
Total Debt
HROW
HROW
NBHC
NBHC
Q1 26
$202.1M
Q4 25
$250.0M
$54.5M
Q3 25
$347.2M
$54.7M
Q2 25
$250.6M
$54.4M
Q1 25
$256.9M
$54.6M
Q4 24
$262.7M
$54.5M
Q3 24
$230.7M
$54.4M
Q2 24
$236.3M
$54.4M
Stockholders' Equity
HROW
HROW
NBHC
NBHC
Q1 26
$1.7B
Q4 25
$52.4M
$1.4B
Q3 25
$47.0M
$1.4B
Q2 25
$49.7M
$1.4B
Q1 25
$56.5M
$1.3B
Q4 24
$69.7M
$1.3B
Q3 24
$58.0M
$1.3B
Q2 24
$58.5M
$1.2B
Total Assets
HROW
HROW
NBHC
NBHC
Q1 26
$12.6B
Q4 25
$399.5M
$9.9B
Q3 25
$363.1M
$10.2B
Q2 25
$345.0M
$10.0B
Q1 25
$364.2M
$10.1B
Q4 24
$389.0M
$9.8B
Q3 24
$351.5M
$10.0B
Q2 24
$306.6M
$10.0B
Debt / Equity
HROW
HROW
NBHC
NBHC
Q1 26
0.12×
Q4 25
4.77×
0.04×
Q3 25
7.39×
0.04×
Q2 25
5.05×
0.04×
Q1 25
4.55×
0.04×
Q4 24
3.77×
0.04×
Q3 24
3.98×
0.04×
Q2 24
4.04×
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
NBHC
NBHC
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
$8.4M
$162.4M
Q3 25
$16.6M
$52.4M
Q2 25
$-803.0K
$32.3M
Q1 25
$19.7M
$39.6M
Q4 24
$-17.8M
$155.3M
Q3 24
$3.0M
$47.0M
Q2 24
$-2.7M
$31.9M
Free Cash Flow
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
FCF Margin
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Capex Intensity
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Cash Conversion
HROW
HROW
NBHC
NBHC
Q1 26
Q4 25
1.27×
10.13×
Q3 25
16.26×
1.48×
Q2 25
-0.16×
0.95×
Q1 25
1.64×
Q4 24
-2.62×
5.51×
Q3 24
1.42×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

NBHC
NBHC

Net Interest Income$108.8M86%
Noninterest Income$18.0M14%

Related Comparisons